Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel
LON:HLN

Haleon Interim Earnings Report

Haleon logo
GBX 343.30 -11.28 (-3.18%)
As of 12:38 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 8.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Interim
Date
7/31/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Sensodyne maker Haleon leverages eye-level shelf placement to outpace rivals: report
September 4 at 8:07 PM  |  msn.comhttps://www.msn.com/en-us/news/other/sensodyne-maker-haleon-leverages-eye-level-shelf-placement-to-outpace-rivals-report/ar-AA2bAULl
Haleon (LON:HLN) Stock Price Up 0.5% - Here's What Happened
September 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30997807
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
September 7 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Haleon Prices $2 Billion in Guaranteed Senior Notes Under New Indenture
August 22, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN/pressreleases/3987862/haleon-prices-2-billion-in-guaranteed-senior-notes-under-new-indenture/
Goldman Sachs Reaffirms Their Buy Rating on Haleon PLC (HLN)
August 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN-N/pressreleases/3590295/goldman-sachs-reaffirms-their-buy-rating-on-haleon-plc-hln/
Haleon Updates Share Capital and Voting Rights Structure
August 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-updates-share-capital-and-voting-rights-structure?utm_source=marketbeat.com&utm_medium=referral
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools